Thomas Reardon is raising $500M at a $2.5B valuation for Flourish, which uses neuroscience to make AI radically less power-hungry. Lux Capital and GV lead the round.

The transition between wakefulness and states of reduced consciousness, whether pharmacologically induced via anesthesia or pathologically necessitated by ...

But overall business investment and consumer spending levels remain resilient — and companies on the S&P 500, the index ...

No official explanation has been provided for the last-minute deferment, despite the minister’s extended stay in the tricity ...

Las Vegas, NV - April 30, 2026 - PRESSADVANTAGE - As U.S. employers report persistent burnout, rising turnover, and ...

A growing research base is catching up to a kind of suffering that mainstream mental health discourse often misses.

Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of ...

Approximately 308,000 people in the United States live with spinal cord injury. Nearly all lose bladder control. And yet the ...

Researchers at the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have uncovered a surprising link between low brain sugar levels and the development of myelin - the ...

National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ...

Researchers discover that the brainstem can reorganize neural circuits within 24 hours to restore sound offset detection ...

New research reveals that high glucose levels drive stem cells to multiply, while low levels signal them to mature into ...